Cet article discusses new discoveries that could lead to improved treatment for a highly aggressive form of cancer in dogs called hemangiosarcoma. Researchers have identified a protein, CD146, that is associated with the spread of this cancer. They have also found that a drug called PX-478, which is known to target CD146, can be effective in killing canine hemangiosarcoma cells in the lab. These findings suggest that PX-478 could be a potential drug for treating hemangiosarcoma in dogs, and further research is needed to confirm its effectiveness in clinical trials.
In response to the question:
The article discusses new research that could lead to improved treatment for hemangiosarcoma, a highly aggressive form of cancer in dogs. The research has identified a protein, CD146, that is associated with the spread of this cancer, and has found that a drug called PX-478, which targets CD146, can be effective in killing canine hemangiosarcoma cells in the lab. This suggests that PX-478 could be a potential drug for treating hemangiosarcoma in dogs, and further research is needed to confirm its effectiveness in clinical trials.